Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing alpha or beta amino acid or substituted amino acid...
Reexamination Certificate
2007-07-31
2010-12-21
Ramirez, Delia M (Department: 1652)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing alpha or beta amino acid or substituted amino acid...
C435S252330, C435S069100, C435S440000, C530S350000, C536S023100
Reexamination Certificate
active
07855060
ABSTRACT:
The present invention provides a method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family, particularly a bacterium belonging the genusEscherichiaorPantoea, wherein said bacterium has attenuated expression of a gene encoding a toxin of a bacterial toxin-antitoxin pair.
REFERENCES:
patent: 6960455 (2005-11-01), Livshits et al.
patent: 7138266 (2006-11-01), Debabov et al.
patent: 7179623 (2007-02-01), Livshits et al.
patent: 7186531 (2007-03-01), Akhverdian et al.
patent: 2003/0148473 (2003-08-01), Livshits et al.
patent: 2004/0132165 (2004-07-01), Akhverdian et al.
patent: 2005/0048631 (2005-03-01), Klyachko et al.
patent: 2005/0054061 (2005-03-01), Klyachko et al.
patent: 2005/0112731 (2005-05-01), Kashiwagi et al.
patent: 2005/0176033 (2005-08-01), Klyachko et al.
patent: 2005/0191684 (2005-09-01), Zimenkov et al.
patent: 2005/0214911 (2005-09-01), Marchenko et al.
patent: 2005/0239175 (2005-10-01), Tabolina et al.
patent: 2006/0014257 (2006-01-01), Katashkina et al.
patent: 2006/0035346 (2006-02-01), Savrasova et al.
patent: 2006/0035348 (2006-02-01), Gulevich et al.
patent: 2006/0040365 (2006-02-01), Kozlov et al.
patent: 2006/0063240 (2006-03-01), Katashkina et al.
patent: 2006/0088919 (2006-04-01), Rybak et al.
patent: 2006/0141586 (2006-06-01), Rybak et al.
patent: 2006/0160192 (2006-07-01), Rybak et al.
patent: 2007/0184532 (2007-08-01), Klyachko et al.
Witkowski et al., Biochemistry 38:11643-11650, 1999.
Seffernick et al., J. Bacteriol. 183(8):2405-2410, 2001.
Branden et al., Introduction to Protein Structure, Garland Publishing Inc., New York, p. 247, 1991.
Zhou et al., Cell Mol Life Sci 63(19-20):2260-2290, 2006.
Kozak, M., Gene 234:187-208, 1999.
Aizenman, E., et al., “AnEscherichia colichromosomal “addiction module” regulated by 3′,5′-bispyrophosphate: A model for programmed bacterial cell death,” Proc. Natl. Acad. Sci. USA 1996;93:6059-6063.
Brown, J. M., et al., “A Novel Family ofEscherichia coliToxin-Antitoxin Gene Pairs,” J. Bacteriol. 2003;185(22):6600-6608.
Chang, D-E., et al., “Gene expression profiling ofEscherichia coligrowth transitions: an expanded stringent response model,” Mol. Microbiol. 2002;45(2):289-306.
Cherny, I., et al., “The YefM Antitoxin Defines a Family of Natively Unfolded Proteins, Implication as a Novel Antibacterial Target,” J. Biol. Chem. 2004;279(9):8252-8261.
Christensen, S. K., et al., “Overproduction of the Lon protease triggers inhibition of translation inEscherichia coli: involvement of theyefM-yoeBtoxin-antitoxin system,” Mol. Microbiol. 2004;51(6):1705-1717.
Christensen, S. K., et al., “RelE, a global inhibitor of translation, is activated during nutritional stress,” PNAS 2001;98(25):14328-14333.
Christensen, S. K., et al., “Toxin-antitoxin Loci as Stress-response-elements: ChpAK/MazF and ChpBK Cleave Translated RNAs and are Counteracted by tmRNA,” J. Mol. Biol. 2003;332:809-819.
Christensen, S. K., et al., “RelE toxins from Bacteria and Archaea cleave mRNAs on translating ribosomes, which are rescued by tmRNA,” Mol. Microbiol. 2003;48(5):1389-1400.
Falla, T. J., et al., “Joint Tolerance to β-Lactam and Fluoroquinolone Antibiotics inEscherichia coliResults from Overexpression ofhipA,” Antimicrob. Agents Chemother. 1998;42(12):3282-3284.
Galvani, C., et al., “Purification of the RelB and RelE Proteins ofEscherichia coli: RelE Binds to RelB and to Ribosomes,” J. Bacteriol. 2001;183(8):2700-2703.
Gerdes, K., “Toxin-Antitoxin Modules May Regulate Synthesis of Macromolecules during Nutritional Stress,” J. Bacteriol. 2000;182(3):561-572.
Gotfredsen, M., et al., “TheEscherichia coli relBEgenes belong to a new toxin-antitoxin gene family,” Mol. Microbiol. 1998;29(4):1065-1076.
Grady, R., et al., “Axe-Txe, a broad-spectrum proteic toxin-antitoxin system specified by a multidrug-resistant, clinical isolate ofEnterococcus faecium,” Mol. Microbiol. 2003;47(5):1419-1432.
Keren, I., et al., “Specialized Persister Cells and the Mechanism of Multidrug Tolerance inEscherichia coli,” J. Bacteriol. 2004; 186(24):8172-8180.
Korch, S. B., et al., “Characterization of thehipA7allele ofEscherichia coliand evidence that high persistence is governed by (p)ppGpp synthesis,” Mol. Microbiol. 2003;50(4):1199-1213.
Muñoz-Gómez, A. J., et al., “Insights into the specificity of RNA cleavage by theEscherichia coliMazF toxin,” FEBS Letters 2004;567:316-320.
Pedersen, K., et al., “Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins,” Mol. Microbiol. 2002;45(2)501-510.
Pedersen, K., et al., “The Bacterial Toxin RelE Displays Codon-Specific Cleavage of mRNAs in the Ribosomal A Site,” Cell 2003;112:131-140.
Rida, S., et al., “Amplification of a Novel Gene,sanA, Abolishes a Vancomycin-Sensitive Defect inEscherichia coli,” J. Bacteriol. 1996;178(1):94-102.
Sat, B., et al., “Programmed Cell Death inEscherichia coli: Some Antibiotics Can TriggermazEFLethality,” J. Bacteriol. 2001;183(6):2041-2045.
Sat, B., et al., “TheEscherichia coli mazEFSuicide Module Mediates Thymineless Death,” J. Bacteriol. 2003;185(6):1803-1807.
Scherrer, R., et al., “Conditional Impairment of Cell Division and Altered Lethality inhipAMutants ofEscherichia coliK-12,” J. Bacteriol. 1988;170(8):3321-3326.
Zhang, J., et al., “Characterization of the Interactions within themazEFAddiction Module ofEscherichia coli,” J. Biol. Chem. 2003;278(34):32300-32306.
Zhang, Y., et al., “MazF Cleaves Cellular mRNAs Specifically at ACA to Block Protein Synthesis inEscherichia coli,” Mol. Cell. 2003;12:912-923.
U.S. Appl. No. 60/586,222, filed Jul. 9, 2004, Akhverdian et al.
U.S. Appl. No. 60/587,492, filed Jul. 14, 2004, Klyachko et al.
U.S. Appl. No. 60/604,698, filed Aug. 27, 2004, Zimenkov et al.
U.S. Appl. No. 60/610,545, filed Sep. 17, 2004, Marchenko et al.
U.S. Appl. No. 60/644,562, filed Jan. 19, 2005, Rybak et al.
U.S. Appl. No. 60/673,807, filed Apr. 22, 2005, Rybak et al.
U.S. Appl. No. 60/693,507, filed Jun. 24, 2005, Rybak et al.
U.S. Appl. No. 60/693,509, filed Jun. 24, 2005, Sheremet'eva et al.
U.S. Appl. No. 60/703,414, filed Jul. 29, 2005, Ptitsyn et al.
U.S. Appl. No. 60/703,444, filed Jul. 29, 2005, Rybak et al.
U.S. Appl. No. 60/703,426, filed Jul. 29, 2005, Rybak et al.
U.S. Appl. No. 60/714,843, filed Sep. 8, 2005, Filippov et al.
U.S. Appl. No. 60/714,844, filed Sep. 8, 2005, Filippov et al.
U.S. Appl. No. 60/714,848, filed Sep. 8, 2005, Filippov et al.
U.S. Appl. No. 60/714,849, filed Sep. 8, 2005, Filippov et al.
U.S. Appl. No. 60/723,566, filed Oct. 5, 2005, Rybak et al.
U.S. Appl. No. 60/723,923, filed Oct. 6, 2005, Filippov et al.
U.S. Appl. No. 60/723,924, filed Oct. 6, 2005, Rybak et al.
U.S. Appl. No. 60/723,925, filed Oct. 6, 2005, Rybak et al.
U.S. Appl. No. 60/723,928, filed Oct. 6, 2005, Rybak et al.
U.S. Appl. No. 60/723,929, filed Oct. 6, 2005, Filippov et al.
U.S. Appl. No. 60/736,830, filed Nov. 16, 2005, Filippov et al.
U.S. Appl. No. 11/275,507, filed Jan. 11, 2006, Ptitsyn et al.
U.S. Appl. No. 60/743,222, filed Feb. 3, 2006, Rybak et al.
U.S. Appl. No. 60/743,223, filed Feb. 3, 2006, Rybak et al.
U.S. Appl. No. 60/743,229, filed Feb. 3, 2006, Rybak et al.
U.S. Appl. No. 60/743,257, filed Feb. 9, 2006, Rybak et al.
U.S. Appl. No. 60/743,258, filed Feb. 9, 2006, Rybak et al.
U.S. Appl. No. 60/806,819, filed Jul. 10, 2006, Rybak et al.
U.S. Appl. No. 60/807,842, filed Jul. 20, 2006, Filippov et al.
U.S. Appl. No. 60/807,843, filed Jul. 20, 2006, Filippov et al.
U.S. Appl. No. 60/807,845, filed Jul. 20, 2006, Filippov et al.
U.S. Appl. No. 60/826,820, filed Sep. 25, 2006, Kotliarova et al.
U.S. Appl. No. 11/536,863, filed Sep. 29, 2006, Zakataeva et al.
U.S. Appl. No. 60/829,697, filed Oct. 17, 2006, Rybak et al.
U.
Filippov Dmitriy Vladimirovich
Gusyatiner Mikhail Markovich
Paraskevov Vitaly Grigorievich
Rybak Konstantin Vyacheslavovich
Sheremet'eva Marina Evgenievna
Ajinomoto Co. Inc.
Cermak Shelly Guest
Cermak Nakajima LLP
Ramirez Delia M
LandOfFree
Method for producing an L-amino acid using a bacterium of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for producing an L-amino acid using a bacterium of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing an L-amino acid using a bacterium of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4156653